Trial intelligence / Profile preview

Palifermin for Oral Mucositis in Multiple Myeloma

NCT00434161Phase 3Completed

Sponsor
Sobi
Start
Dec 2006
Primary completion
Mar 2009
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of palifermin in oral mucositis (OM), sponsored by Sobi. Started Dec 2006; status: completed.

02

Drugs

palifermin
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT00434161.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00434161.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call